Skip to main content
Top
Published in: Hepatology International 2/2011

01-06-2011 | Original Article

Assessment of hepatocellular carcinomas using conventional magnetic resonance imaging correlated with histological differentiation and a serum marker of poor prognosis

Authors: Shotaro Enomoto, Hideyuki Tamai, Naoki Shingaki, Yoshiyuki Mori, Kosaku Moribata, Tatsuya Shiraki, Hisanobu Deguchi, Kazuki Ueda, Izumi Inoue, Takao Maekita, Mikitaka Iguchi, Kimihiko Yanaoka, Masashi Oka, Masao Ichinose

Published in: Hepatology International | Issue 2/2011

Login to get access

Abstract

Purpose

To establish a method of assessing the malignant potential of hepatocellular carcinoma (HCC) using magnetic resonance imaging (MRI).

Methods

For 69 nodules [12 Edmondson (Ed)-I, 48 Ed-II, 9 Ed-III] in 54 HCC patients, signal intensity patterns and enhancement patterns of gadopentate dimeglumine (Gd-DTPA) dynamic studies were correlated with histological differentiation and serum lens culinaris agglutinin-reactive alpha-fetoprotein (AFP-L3) level, which is an indicator of poor prognosis.

Results

Hypointensity on T1-weighted imaging was seen in 17, 72, and 89% of Ed-I, Ed-II, and Ed-III HCCs, respectively (P < 0.001). Meanwhile, hyperintensity on T2-weighted imaging was seen in 42, 88, and 89% (P < 0.005). Tumor stain during the arterial phase of Gd dynamic MRI was seen in 75, 86, and 89%. Tumor stain washout during the portal phase was seen in 43% of Ed-II and 100% of Ed-III HCCs (P < 0.005). In the Ed-II and Ed-III HCCs, hypointensity on T1-weighted imaging was seen in 65% of AFP-L3-negative HCCs and 90% of AFP-L3-positive HCCs (P = 0.071). Washout of tumor stain during the portal phase was seen in 39% of AFP-L3-negative HCCs and 75% of AFP-L3-positive HCCs (P < 0.05).

Conclusions

Although hyperintensity of tumor on T2-weighted imaging and arterial hypervascularity of tumor are considered to be useful for differential diagnosis between well differentiated HCCs and moderately/poorly differentiated HCCs, hypointensity of tumor on T1-weighted imaging and tumor stain washout during the portal phase of Gd-DTPA dynamic MRI reflected poorer histological differentiation of HCCs and correlated with AFP-L3 levels.
Literature
1.
go back to reference Theise ND. Macroregenerative (dysplastic) nodules and hepatocarcinogenesis: theoretical and clinical considerations. Semin Liver Dis 1995;15:360–371PubMedCrossRef Theise ND. Macroregenerative (dysplastic) nodules and hepatocarcinogenesis: theoretical and clinical considerations. Semin Liver Dis 1995;15:360–371PubMedCrossRef
2.
go back to reference Kudo M. Multistep human hepatocarcinogenesis: correlation of imaging with pathology. J Gastroenterol 2009;44(Suppl 19):112–118PubMedCrossRef Kudo M. Multistep human hepatocarcinogenesis: correlation of imaging with pathology. J Gastroenterol 2009;44(Suppl 19):112–118PubMedCrossRef
3.
go back to reference Sato M, Watanabe Y, Lee T, Kito K, Kimura S, Itoh Y, Akamatsu K, Ueda N. Well-differentiated hepatocellular carcinoma: clinicopathological features and results of hepatic resection. Am J Gastroenterol 1995;90:112–116PubMed Sato M, Watanabe Y, Lee T, Kito K, Kimura S, Itoh Y, Akamatsu K, Ueda N. Well-differentiated hepatocellular carcinoma: clinicopathological features and results of hepatic resection. Am J Gastroenterol 1995;90:112–116PubMed
4.
go back to reference Yamamoto M, Takasaki K, Otsubo T, Katsuragawa H, Katagiri S, Yoshitoshi K, Ariizumi S, Saito A, Nakano M. Favorable surgical outcomes in patients with early hepatocellular carcinoma. Ann Surg 2004;239:395–399PubMedCrossRef Yamamoto M, Takasaki K, Otsubo T, Katsuragawa H, Katagiri S, Yoshitoshi K, Ariizumi S, Saito A, Nakano M. Favorable surgical outcomes in patients with early hepatocellular carcinoma. Ann Surg 2004;239:395–399PubMedCrossRef
5.
go back to reference Maeda T, Shimada M, Harimoto N, Tsujita E, Aishima S, Tanaka S, Shirabe K, Maehara Y. Prognosis of early hepatocellular carcinoma after hepatic resection. Hepatogastroenterology 2008;55:1428–1432PubMed Maeda T, Shimada M, Harimoto N, Tsujita E, Aishima S, Tanaka S, Shirabe K, Maehara Y. Prognosis of early hepatocellular carcinoma after hepatic resection. Hepatogastroenterology 2008;55:1428–1432PubMed
6.
go back to reference Kim SH, Lim HK, Kim MJ, Choi D, Rhim H, Park CK. Radiofrequency ablation of high-grade dysplastic nodules in chronic liver disease: comparison with well-differentiated hepatocellular carcinoma based on long-term results. Eur Radiol 2008;18:814–821PubMedCrossRef Kim SH, Lim HK, Kim MJ, Choi D, Rhim H, Park CK. Radiofrequency ablation of high-grade dysplastic nodules in chronic liver disease: comparison with well-differentiated hepatocellular carcinoma based on long-term results. Eur Radiol 2008;18:814–821PubMedCrossRef
7.
go back to reference Sasaki Y, Imaoka S, Ishiguro S, Nakano H, Kasugai H, Fujita M, Inoue E, Ishikawa O, Furukawa H, Nakamori S, Kuroda C, Iwanaga T. Clinical features of small hepatocellular carcinomas as assessed by histologic grades. Surgery 1996;119:252–260PubMedCrossRef Sasaki Y, Imaoka S, Ishiguro S, Nakano H, Kasugai H, Fujita M, Inoue E, Ishikawa O, Furukawa H, Nakamori S, Kuroda C, Iwanaga T. Clinical features of small hepatocellular carcinomas as assessed by histologic grades. Surgery 1996;119:252–260PubMedCrossRef
8.
go back to reference Oishi K, Itamoto T, Amano H, Fukuda S, Ohdan H, Tashiro H, Shimamoto F, Asahara T. Clinicopathologic features of poorly differentiated hepatocellular carcinoma. J Surg Oncol 2007;95:311–316PubMedCrossRef Oishi K, Itamoto T, Amano H, Fukuda S, Ohdan H, Tashiro H, Shimamoto F, Asahara T. Clinicopathologic features of poorly differentiated hepatocellular carcinoma. J Surg Oncol 2007;95:311–316PubMedCrossRef
9.
go back to reference Akamatsu M, Ishikawa T, Shiratori Y, Koike Y, Shiina S, Teratani T, Hamamura K, Obi S, Sato S, Tateishi R, Fujishima T, Imai Y, Yoshida H, Omata M. Factors predisposing to poorly differentiated hepatocellular carcinoma and its recurrence. Hepatogastroenterology 2005;52:391–397PubMed Akamatsu M, Ishikawa T, Shiratori Y, Koike Y, Shiina S, Teratani T, Hamamura K, Obi S, Sato S, Tateishi R, Fujishima T, Imai Y, Yoshida H, Omata M. Factors predisposing to poorly differentiated hepatocellular carcinoma and its recurrence. Hepatogastroenterology 2005;52:391–397PubMed
10.
go back to reference Kim SH, Lim HK, Choi D, Lee WJ, Kim MJ, Kim CK, Jeon YH, Lee JM, Rhim H. Percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of histologic grade on therapeutic results. AJR Am J Roentgenol 2006;186:S327–S333.PubMedCrossRef Kim SH, Lim HK, Choi D, Lee WJ, Kim MJ, Kim CK, Jeon YH, Lee JM, Rhim H. Percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of histologic grade on therapeutic results. AJR Am J Roentgenol 2006;186:S327–S333.PubMedCrossRef
11.
go back to reference Fukuda S, Itamoto T, Nakahara H, Kohashi T, Ohdan H, Hino H, Ochi M, Tashiro H, Asahara T. Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma. Hepatogastroenterology 2005;52:1163–1167PubMed Fukuda S, Itamoto T, Nakahara H, Kohashi T, Ohdan H, Hino H, Ochi M, Tashiro H, Asahara T. Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma. Hepatogastroenterology 2005;52:1163–1167PubMed
12.
go back to reference Portolani N, Tiberio GA, Ronconi M, Coniglio A, Ghidoni S, Gaverini G, Giulini SM. Aggressive recurrence after radiofrequency ablation of liver neoplasms. Hepatogastroenterology 2003;50:2179–2184PubMed Portolani N, Tiberio GA, Ronconi M, Coniglio A, Ghidoni S, Gaverini G, Giulini SM. Aggressive recurrence after radiofrequency ablation of liver neoplasms. Hepatogastroenterology 2003;50:2179–2184PubMed
13.
go back to reference Takada Y, Kurata M, Ohkohchi N. Rapid and aggressive recurrence accompanied by portal tumor thrombus after radiofrequency ablation for hepatocellular carcinoma. Int J Clin Oncol 2003;8:332–335PubMedCrossRef Takada Y, Kurata M, Ohkohchi N. Rapid and aggressive recurrence accompanied by portal tumor thrombus after radiofrequency ablation for hepatocellular carcinoma. Int J Clin Oncol 2003;8:332–335PubMedCrossRef
14.
go back to reference Nicoli N, Casaril A, Hilal MA, Mangiante G, Marchiori L, Ciola M, Invernizzi L, Campagnaro T, Mansueto G. A case of rapid intrahepatic dissemination of hepatocellular carcinoma after radiofrequency thermal ablation. Am J Surg 2004;188:165–167PubMedCrossRef Nicoli N, Casaril A, Hilal MA, Mangiante G, Marchiori L, Ciola M, Invernizzi L, Campagnaro T, Mansueto G. A case of rapid intrahepatic dissemination of hepatocellular carcinoma after radiofrequency thermal ablation. Am J Surg 2004;188:165–167PubMedCrossRef
15.
go back to reference Ruzzenente A, Manzoni GD, Molfetta M, Pachera S, Genco B, Donataccio M, Guglielmi A. Rapid progression of hepatocellular carcinoma after Radiofrequency Ablation. World J Gastroenterol 2004;10:1137–1140PubMed Ruzzenente A, Manzoni GD, Molfetta M, Pachera S, Genco B, Donataccio M, Guglielmi A. Rapid progression of hepatocellular carcinoma after Radiofrequency Ablation. World J Gastroenterol 2004;10:1137–1140PubMed
16.
go back to reference Imamura J, Tateishi R, Shiina S, Goto E, Sato T, Ohki T, Masuzaki R, Goto T, Yoshida H, Kanai F, Hamamura K, Obi S, Omata M. Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma. Am J Gastroenterol 2008;103:3057–3062PubMedCrossRef Imamura J, Tateishi R, Shiina S, Goto E, Sato T, Ohki T, Masuzaki R, Goto T, Yoshida H, Kanai F, Hamamura K, Obi S, Omata M. Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma. Am J Gastroenterol 2008;103:3057–3062PubMedCrossRef
17.
go back to reference Llovet JM, Vilana R, Bru C, Bianchi L, Salmeron JM, Boix L, Ganau S, Sala M, Pages M, Ayuso C, Sole M, Rodes J, Bruix J. Increased risk of tumour seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001;33:1124–1129PubMedCrossRef Llovet JM, Vilana R, Bru C, Bianchi L, Salmeron JM, Boix L, Ganau S, Sala M, Pages M, Ayuso C, Sole M, Rodes J, Bruix J. Increased risk of tumour seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001;33:1124–1129PubMedCrossRef
18.
go back to reference Mori Y, Tamai H, Shingaki N, Moribata K, Shiraki T, Deguchi H, Ueda K, Enomoto S, Magari H, Inoue I, Maekita T, Iguchi M, Yanaoka K, Oka M, Ichinose M. Diffuse intrahepatic recurrence after percutaneous radiofrequency ablation for solitary and small hepatocellular carcinoma. Hepatol Int 2009;3:509–515CrossRef Mori Y, Tamai H, Shingaki N, Moribata K, Shiraki T, Deguchi H, Ueda K, Enomoto S, Magari H, Inoue I, Maekita T, Iguchi M, Yanaoka K, Oka M, Ichinose M. Diffuse intrahepatic recurrence after percutaneous radiofrequency ablation for solitary and small hepatocellular carcinoma. Hepatol Int 2009;3:509–515CrossRef
19.
go back to reference Miyaaki H, Nakashima O, Kurogi M, Eguchi K, Kojiro M. Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma. J Gastroenterol 2007;42:962–968PubMedCrossRef Miyaaki H, Nakashima O, Kurogi M, Eguchi K, Kojiro M. Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma. J Gastroenterol 2007;42:962–968PubMedCrossRef
20.
go back to reference Yamashita F, Tanaka M, Satomura S, Tanikawa K. Prognostic significance of Lens culinaris agglutinin A-reactive alpha-fetoprotein in small hepatocellular carcinomas. Gastroenterology 1996;111:996–1001PubMedCrossRef Yamashita F, Tanaka M, Satomura S, Tanikawa K. Prognostic significance of Lens culinaris agglutinin A-reactive alpha-fetoprotein in small hepatocellular carcinomas. Gastroenterology 1996;111:996–1001PubMedCrossRef
21.
go back to reference Tada T, Kumada T, Toyoda H, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kitabatake S, Kuzuya T, Nonogaki K, Shimizu J, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J, Satomura S. Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma. Liver Int 2005;25:848–853PubMedCrossRef Tada T, Kumada T, Toyoda H, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kitabatake S, Kuzuya T, Nonogaki K, Shimizu J, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J, Satomura S. Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma. Liver Int 2005;25:848–853PubMedCrossRef
22.
go back to reference Muramatsu Y, Nawano S, Takayasu K, Moriyama N, Yamada T, Yamasaki S, Hirohashi S. Early hepatocellular carcinoma: MR imaging. Radiology 1991;181:209–213PubMed Muramatsu Y, Nawano S, Takayasu K, Moriyama N, Yamada T, Yamasaki S, Hirohashi S. Early hepatocellular carcinoma: MR imaging. Radiology 1991;181:209–213PubMed
23.
go back to reference Kadoya M, Matsui O, Takashima T, Nonomura A. Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. Radiology 1992;183:819–825PubMed Kadoya M, Matsui O, Takashima T, Nonomura A. Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. Radiology 1992;183:819–825PubMed
24.
go back to reference Ebara M, Fukuda H, Kojima Y, Morimoto N, Yoshikawa M, Sugiura N, Satoh T, Kondo F, Yukawa M, Matsumoto T, Saisho H. Small hepatocellular carcinoma: relationship of signal intensity to histopathologic findings and metal content of the tumour and surrounding hepatic parenchyma. Radiology 1999;210:81–88PubMed Ebara M, Fukuda H, Kojima Y, Morimoto N, Yoshikawa M, Sugiura N, Satoh T, Kondo F, Yukawa M, Matsumoto T, Saisho H. Small hepatocellular carcinoma: relationship of signal intensity to histopathologic findings and metal content of the tumour and surrounding hepatic parenchyma. Radiology 1999;210:81–88PubMed
25.
go back to reference Kelekis NL, Semelka RC, Worawattanakul S, de Lange EE, Ascher SM, Ahn IO, Reinhold C, Remer EM, Brown JJ, Bis KG, Woosley JT, Mitchell DG. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images. AJR Am J Roentgenol 1998;170:1005–1013PubMed Kelekis NL, Semelka RC, Worawattanakul S, de Lange EE, Ascher SM, Ahn IO, Reinhold C, Remer EM, Brown JJ, Bis KG, Woosley JT, Mitchell DG. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images. AJR Am J Roentgenol 1998;170:1005–1013PubMed
26.
go back to reference Van Beers B, Demeure R, Pringot J, Defalque D, Geubel A, Gigot JF, Jamart J. Dynamic spin-echo imaging with Gd-DTPA: value in the differentiation of hepatic tumours. AJR Am J Roentgenol 1990;154:515–519PubMed Van Beers B, Demeure R, Pringot J, Defalque D, Geubel A, Gigot JF, Jamart J. Dynamic spin-echo imaging with Gd-DTPA: value in the differentiation of hepatic tumours. AJR Am J Roentgenol 1990;154:515–519PubMed
27.
go back to reference Peterson MS, Baron RL, Murakami T. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging. Radiology 1996;201:337–345PubMed Peterson MS, Baron RL, Murakami T. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging. Radiology 1996;201:337–345PubMed
28.
go back to reference Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954;7:462–503PubMedCrossRef Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954;7:462–503PubMedCrossRef
29.
go back to reference Honda H, Kaneko K, Maeda T, Kuroiwa T, Fukuya T, Yoshimitsu K, Irie H, Aibe H, Takenaka K, Masuda K. Small hepatocellular carcinoma on magnetic resonance imaging. Relation of signal intensity to angiographic and clinicopathologic findings. Invest Radiol 1997;32:161–168PubMedCrossRef Honda H, Kaneko K, Maeda T, Kuroiwa T, Fukuya T, Yoshimitsu K, Irie H, Aibe H, Takenaka K, Masuda K. Small hepatocellular carcinoma on magnetic resonance imaging. Relation of signal intensity to angiographic and clinicopathologic findings. Invest Radiol 1997;32:161–168PubMedCrossRef
30.
go back to reference Yamashita Y, Fan ZM, Yamamoto H, Matsukawa T, Yoshimatsu S, Miyazaki T, Sumi M, Harada M, Takahashi M. Spin-echo and dynamic gadolinium-enhanced FLASH MR imaging of hepatocellular carcinoma: correlation with histopathologic findings. J Magn Reson Imaging 1994;4:83–90PubMedCrossRef Yamashita Y, Fan ZM, Yamamoto H, Matsukawa T, Yoshimatsu S, Miyazaki T, Sumi M, Harada M, Takahashi M. Spin-echo and dynamic gadolinium-enhanced FLASH MR imaging of hepatocellular carcinoma: correlation with histopathologic findings. J Magn Reson Imaging 1994;4:83–90PubMedCrossRef
31.
go back to reference Kudo M, Okanoue T. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology 2007;72(Suppl 1):2–15PubMedCrossRef Kudo M, Okanoue T. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology 2007;72(Suppl 1):2–15PubMedCrossRef
Metadata
Title
Assessment of hepatocellular carcinomas using conventional magnetic resonance imaging correlated with histological differentiation and a serum marker of poor prognosis
Authors
Shotaro Enomoto
Hideyuki Tamai
Naoki Shingaki
Yoshiyuki Mori
Kosaku Moribata
Tatsuya Shiraki
Hisanobu Deguchi
Kazuki Ueda
Izumi Inoue
Takao Maekita
Mikitaka Iguchi
Kimihiko Yanaoka
Masashi Oka
Masao Ichinose
Publication date
01-06-2011
Publisher
Springer-Verlag
Published in
Hepatology International / Issue 2/2011
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-010-9245-8

Other articles of this Issue 2/2011

Hepatology International 2/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.